Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
09/2003
09/02/2003US6613757 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
08/2003
08/28/2003WO2003070772A1 Starch derivatives, starch active substance conjugates, method for the production thereof and their use as medicaments
08/28/2003WO2003070765A2 Growth hormone fusion protein
08/28/2003WO2003070745A2 Carbonate and carbamate modified forms of glucocorticoids
08/28/2003WO2003070716A1 Vitamin d3 derivatives and remedies using the same
08/28/2003WO2003070675A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors
08/28/2003WO2003070244A1 Antagonist of melanin concentrating hormone and their uses
08/28/2003WO2003070217A1 Levothyroxine compositions and methods
08/28/2003WO2003070188A2 Method of treating trx mediated diseases
08/28/2003WO2003062259A3 Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
08/28/2003WO2003016335A3 Irreversible cysteine protease inhibitors of legumain
08/28/2003WO2003015693A3 Screening and therapeutic methods for promoting wakefulness and sleep
08/28/2003WO2003013434A3 Methods and compositions for treating diseases associated with excesses in ace
08/28/2003WO2003002559A3 Piperidine compounds for use as orexin receptor antagonist
08/28/2003WO2003002058A3 Bone anabolic compounds and methods of use
08/28/2003WO2002097044A3 Alternative splice forms of proteins as basis for multiple therapeutic modalities
08/28/2003WO2002094192A3 Antibodies against tumor necrosis factor delta (april)
08/28/2003WO2002015885A3 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
08/28/2003WO2002008399A3 Human kinases
08/28/2003WO2001095859A3 Novel heterocyclic analogs of diphenylethylene compounds
08/28/2003US20030163834 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
08/28/2003US20030162974 Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens
08/28/2003US20030162830 3,4-diphenyl-bicyclo(4.3.0)nonyl derivatives
08/28/2003US20030162811 Heterocyclic amines such as 4-(3'-Thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
08/28/2003US20030162808 Acetindine derivatives, their preparation and medicaments containing them
08/28/2003US20030162807 Compositions and methods for treating osteoporosis and lowering cholesterol
08/28/2003US20030162802 Preferential enzyme inhibitors such as 2-((4-6-pyrimidinedion -2-yl)amino)-4-methyl-5-thiazolecarboxylic acid ethyl ester, used for prophylaxis of lymphocyte associated disorders
08/28/2003US20030162786 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein
08/28/2003US20030162767 Novel 1,3-dihydro-2h-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them
08/28/2003US20030162256 PTH1R and PTH3R receptors, methods and uses thereof
08/28/2003US20030162229 Immuno-interactive fragments of the alpha-C subunit of inhibin
08/28/2003US20030162196 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders
08/28/2003US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies
08/28/2003CA2476679A1 Vitamin d3 derivatives and remedies using the same
08/28/2003CA2476434A1 Method of treating trx mediated diseases
08/28/2003CA2440190A1 Levothyroxine compositions and methods
08/27/2003EP1338600A1 Fused 1,2,4-Thiadiazine derivatives, their preparation and use
08/27/2003EP1337560A2 Truncated cd200
08/27/2003EP1337544A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
08/27/2003EP1337527A1 Indolylmaleimide derivatives as protein kinase c inhibitors
08/27/2003EP1337247A1 Gaba enhancers in the treatment of diseases relating to reduced neurosteroid activity
08/27/2003EP1267834A4 Cationic liposomes
08/27/2003EP1140889B1 Compounds and methods for modulation of estrogen receptors
08/27/2003EP0885005B1 Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination to produce a medicament for treating relative and absolute androgen deficiency in men
08/27/2003CN1439021A Parathyroid hormone and parathyroid hormone-related protein receptor modulators
08/27/2003CN1439010A Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
08/27/2003CN1438997A Inhibitors of 11-beta-hydroxy steroid dehydrogenase typeÔàá"
08/27/2003CN1438894A Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking LFA-1 medicated adhesion
08/27/2003CN1438893A Therapeutical use of sophora flavescens or sophora subprostrated extracts
08/27/2003CN1438881A The Controlled release preparation of insulin and its method
08/27/2003CN1438244A Self-body immunity-disease related egg-yolk atibody preparation method and use thereof
08/27/2003CN1437948A Composition containing resveratrol and resveratr-glycoside and its use
08/27/2003CN1119421C Recombinant fusion proteins to growth hormone and serum albumin
08/26/2003US6610847 Tyrosine kinase inhibitors; immunosuppressants
08/26/2003US6610744 Methods of treatment with compounds having RARα receptor specific or selective activity
08/26/2003US6610737 Non-psychotropic cannabinoids
08/26/2003US6610733 Optically active chroman and thiochroman derivatives
08/26/2003US6610688 For therapy of blood vessel proliferative disorders; fibrotic disorders; mesangial cell proliferative disorders; metabolic disorders; allergies; asthma; thrombosis; nervous system diseases; and cancer
08/26/2003US6610685 Fused indole derivatives
08/26/2003US6610683 Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
08/26/2003US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds
08/21/2003WO2003068812A2 Immune-modulating peptide made of s. aureus enterotoxin b
08/21/2003WO2003068769A1 Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
08/21/2003WO2003068743A1 Chemical compounds
08/21/2003WO2003068314A1 Pulmonary administration of 6-alpha-alkylated testosterone derivatives for androgen replacement therapy
08/21/2003WO2003068234A1 Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
08/21/2003WO2003068232A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003WO2003068217A1 Biphenil derivatives and their use as antiandrogenic agents
08/21/2003WO2003068202A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
08/21/2003WO2003068199A1 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta
08/21/2003WO2003068197A1 Method for systemic drug delivery through the nail
08/21/2003WO2003068140A2 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
08/21/2003WO2003044056A3 Chemically-modified human growth hormone conjugates
08/21/2003WO2003027075A3 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
08/21/2003WO2002062844A3 Long lasting growth hormone releasing factor derivatives
08/21/2003WO2002057452A3 Human proteins, polynucleotides encoding them and methods of using the same
08/21/2003US20030158414 Process for preparing growth hormone secretagogues
08/21/2003US20030158381 Novel insulin/igf/relaxin family polypeptides and dnas thereof
08/21/2003US20030158238 Treating diseases such as cancer, inflammatory disorders, restenosis,
08/21/2003US20030158225 Novel compounds
08/21/2003US20030158217 Succinate and malonate complexes treatment of abnormal cell growth, such as cancer, and overexpression of erbB2, and inducing cell death
08/21/2003US20030158197 Certain alkylene diamine-substituted heterocycles
08/21/2003US20030158182 Cyanopyrroles
08/21/2003US20030158168 Composition for combined use of aromatase inhibitors
08/21/2003US20030158160 Pharmaceutical combination of an anti-androgen and tamoxifen for providing an anti-androgenic effect and aromatase inhibition
08/21/2003US20030158106 Use of fsh for treating infertility
08/21/2003US20030158087 Novel use of fulmonary surfactant for the prophylaxis or early treatment if acute fulmonary diseases
08/21/2003US20030157225 Food product and process
08/21/2003US20030157108 80-100% of the glycoprotein has a mature core carbohydrate structure which lacks fucose, attached to a Fc region
08/21/2003DE19937304C2 Verwendung von CGRP-Antagonisten zur Bekämpfung menopausaler Hitzewallungen Use of CGRP antagonists for the control of menopausal hot flushes
08/21/2003CA2475708A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003CA2475439A1 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
08/21/2003CA2474171A1 Biphenil derivatives and their use as antiandrogenic agents
08/21/2003CA2472822A1 Chemical compounds
08/20/2003EP1336600A2 Dimer-selective RXR modulators and methods for their use
08/20/2003EP1335901A1 Pharmaceutically active sulfanilide derivatives
08/20/2003EP1335724A1 Novel use of certain insulin sensitizers or ppar-gamma agonists
08/20/2003EP1212327B1 Pyrazolopyrimidines as therapeutic agents
08/20/2003CN1437595A Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals
08/20/2003CN1437594A Substituted bicyclic derivatives for the treatment of abnormal cell growth
1 ... 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 ... 290